Dear Sir/Madam, Please find enclosed the official Press Release titled "Earkart''s OMNI Shines at World''s Largest Otolaryngology Conference, Empowering Global ENT Innovation." A ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Earkart unveiled its next-generation OMNI platform — a remote ENT diagnostic tool — at the world's largest otolaryngology conference held in Indianapolis, USA from October 11–13, 2025. The event drew over 5,000 ENT specialists, audiologists and healthcare leaders from 75+ countries across 520+ sessions. Earkart's booth saw live demonstrations and a surge in registration forms, with multiple specialists expressing intent to adopt OMNI. The company is positioning OMNI for expansion into North America, Europe, the Middle East and emerging markets. For context, Earkart is a hearing healthcare solutions provider with 49 Shop-in-Shop clinics across 22 cities, a Noida manufacturing facility (4,500 sq ft), and a revenue mix of 69% government and 29% private. No new financial figures, contracts, or revenue figures were disclosed in this filing.
This is a brand visibility and product showcase announcement rather than a financial event — no contracts, orders, or revenue numbers are disclosed. Positive for sentiment as it signals global ambition and product-market interest, but retail investors should wait for concrete commercial outcomes before treating it as a material catalyst for the stock.